Trillium Therapeutics Inc. (TRIL) Fell -8.83% or -0.06 To Price $0.67 On Monday


Trillium Therapeutics Inc. (TRIL) fell -8.83% or -0.06 to $0.67. It is close to 761421 shares traded, which is 155.4% compare to the average total volume 489960. The market cap of TRIL is $14.17 million. The year to date change is -71.12%. The 52 week price range is from $0.65 to $8.4. Price of TRIL have changed 5.72% during last week. It have changed -41.00% over last month, -64.49% over last 3 months, -87.70% over last 6 months and -90.44% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TRIL is 1.43. It is 113.43% above current price. The 200-day Moving Averages for TRIL is 3.94. It is 488.06% above current price. The 52-week High is 8.4. It is 1153.73% from the current price. The 52-week Low is 0.65. It is -2.99% from current price.

There are some statistics of TRIL. It is has market cap $14.17 million. The share outstanding is 21.24 million. The average volume is 489960. The percent of top 15 Institution holding is 50.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TRIL is -643.63%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TRIL is -63.48%.


Tags:

Share this post